Endra Life Sciences to Merge and Rebrand as Noble Africa
Endra Life Sciences Inc. (NASDAQ: NDRA) has signed a definitive merger agreement to join forces with Noble Africa LLC. The deal triggers a wholesale corporate transformation, including a name change to Noble Africa Inc. and a planned reverse stock split. According to a June 29, 2026, Schedule 13D/A filing with the U.S. Securities and Exchange Commission, company director Anthony DiGiandomenico has pledged his 9.9% stake in support of the transaction.
The Mechanics of the Merger
Finalized on June 25, 2026, the agreement ropes in a complex web of entities: ASP Isotopes Inc., Noble Africa LLC, Renergen Limited, and Kruger Merger Sub LLC. The structure dictates that Kruger Merger Sub LLC, a wholly-owned Endra subsidiary, will merge with Noble Africa, and Noble Africa will remain as a wholly-owned subsidiary of the parent firm.
The restructuring demands significant shareholder approval. The board is seeking the green light for the issuance of Class A and Class B common stock, the formal adoption of a new stock incentive plan, and the introduction of a dual-class share structure. The reverse stock split is explicitly designed to keep the company in line with Nasdaq listing requirements.
Director Backing and Voting Power
Anthony DiGiandomenico, a board member since 2013, has locked himself into the deal. He executed a voting agreement that legally binds him to support the merger and all associated governance changes at the upcoming special meeting of shareholders. He is also prohibited from backing any alternative transactions that might impede the merger.
SEC filings detail DiGiandomenico’s holdings at 196,692 shares. This figure comprises 76,267 shares of common stock, nine shares via option exercises, and 120,416 shares through warrants. To satisfy a 9.99% ownership limitation clause, 21,228 shares underlying certain warrants were excluded from his beneficial ownership total.
A Decade of Capital Accumulation
DiGiandomenico’s position is the result of years of market activity and board compensation. Between 2020 and October 2025, he invested personal funds into 70,824 shares of common stock through both public and private offerings. On June 11, 2026, he added to that tally by converting 5,384 Restricted Stock Units (RSUs) into common stock.
Outside of Endra, DiGiandomenico is a co-founder of MDB Capital Group LLC. His boardroom experience extends to ClearSign Technologies Corporation (NASDAQ: CLIR) and Illumination Acquisition Corp. I (NASDAQ: ILLU).
Shifting Strategic Priorities
By locking in a director with a 9.9% stake, the board is projecting a unified front ahead of the shareholder vote. Investors should consult official SEC filings for the full terms of the merger and the specific impact the proposed reverse stock split will have on their individual holdings.
Worth a look